BioSpace News Archive

TOMI Environmental Solutions, Inc.® today announced that Dr. Halden Shane, Chief Executive Officer, will be presenting at the LD Micro Main Event on Tuesday, October 12, 2021 at 6:30 P.M. ET

Elixirgen Therapeutics, Inc. today announced it has entered into an exclusive licensing agreement with a global pharmaceutical company (currently undisclosed) for the rights to commercialize its self-replica

Alpha Cognition Inc., a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating neurodegenerative disorders, is pleased to announce that it will be presenting at the 14th annual Main Event on Tuesday, October 12th at 3:00 PM EST at the Luxe Sunset Bel-Air in Los Angeles.

Pacific Cancer Care and Deep Lens today announced that they are collaborating to optimize clinical trial matching and accelerate enrollment at the Monterey-based practice through the use of Deep Lens’ artificial-intelligence (AI) based solutions and other services.

Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced the presentation of preliminary Phase 1 monotherapy clinical data from its Phase 1/2 TRESR (Treatment Enabled by SNIPRx) clinical trial of RP-3500.

Black Diamond Therapeutics, Inc., a precision oncology medicine company pioneering the discovery and development of MasterKey therapies, announced the presentation of preclinical data for three early-stage pipeline programs in oral and poster sessions at the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics.

Adamas Pharmaceuticals, Inc. announced that the compensation committee of the company’s board of directors granted eight new employees restricted stock units to acquire 106,500 shares of the company’s common stock.

Enzyvant announced the U.S. Food and Drug Administration approval of RETHYMIC®, a one-time regenerative tissue-based therapy for immune reconstitution in pediatric patients with congenital athymia.

OncoNano Medicine Announces Positive Preclinical Data for ONM-501 at AACR Virtual Conference on Tumor Immunology and Immunotherapy

Emerson Ecologics announces LabsLive 2021 . The virtual event, taking place on Oct. 16, 2021, will discuss the future applications of diagnostic medicine and introduce the latest tool in the Wellevate® Connected Care platform, Wellevate Labs.